BCAM
Boston Common Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,333
| Closed | -$1.02M | – | 298 |
|
|
2022
Q4 | $1.02M | Buy |
6,333
+153
| +2% | +$24.7K | 0.05% | 163 |
|
|
2022
Q3 | $829K | Buy |
6,180
+101
| +2% | +$13.5K | 0.04% | 173 |
|
|
2022
Q2 | $931K | Buy |
6,079
+534
| +10% | +$81.8K | 0.05% | 176 |
|
|
2022
Q1 | $899K | Sell |
5,545
-663
| -11% | -$107K | 0.04% | 173 |
|
|
2021
Q4 | $841K | Buy |
6,208
+336
| +6% | +$45.5K | 0.03% | 181 |
|
|
2021
Q3 | $633K | Buy |
5,872
+39
| +0.7% | +$4.2K | 0.03% | 193 |
|
|
2021
Q2 | $657K | Buy |
5,833
+400
| +7% | +$45.1K | 0.03% | 199 |
|
|
2021
Q1 | $588K | Buy |
5,433
+51
| +0.9% | +$5.52K | 0.04% | 199 |
|
|
2020
Q4 | $577K | Buy |
+5,382
| New | +$577K | 0.04% | 189 |
|